Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

Home Publications Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

By Dansk Børne Astma Center | Publications | Comments are Closed | 11 august, 2002 | 0

J Allergy Clin Immunol. 2002 Aug
Asmus MJ, Hendeles L, Weinberger M, Ahrens RC, Bisgaard H, Lötvall J, O’Byrne PM, Cockcroft DW.

Comment on
Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. [J Allergy Clin Immunol. 2001]

PMID: 12170277

No tags.

Next Previous

Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

KONTAKT